Cargando…
Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease
The blood–brain barrier (BBB) is a major obstacle to the development of effective therapeutics for central nervous system (CNS) disorders, including Alzheimer’s disease (AD). This has been particularly true in the case of monoclonal antibody (mAbs) therapeutic candidates, due to their large size. To...
Autores principales: | Gagnon, Maxime, Savard, Martin, Tran, Thi Minh Hue, Vincent, Laurence, Moquin, Alexandre, Tremblay, Philippe, Roucou, Xavier, Dory, Yves, Gobeil, Fernand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343654/ https://www.ncbi.nlm.nih.gov/pubmed/37446867 http://dx.doi.org/10.3390/molecules28135206 |
Ejemplares similares
-
Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene
por: Gagnon, Maxime, et al.
Publicado: (2021) -
Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model
por: Côté, Jérôme, et al.
Publicado: (2012) -
Correction: Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model
por: Côté, Jérôme, et al.
Publicado: (2012) -
Characterization of moderate tendinopathy in ex vivo stress-deprived rat tail tendons
por: Jafari, Leila, et al.
Publicado: (2019) -
Structures of adenosine receptor A(2B)R bound to endogenous and synthetic agonists
por: Cai, Hongmin, et al.
Publicado: (2022)